Fundraising Fox

Biomason

Research Triangle Park, US · Founded 2012 · Delaware corporation · 58 employees on LinkedIn · 5 known investors

Biomason uses biotechnology to grow biocement, producing concrete and tile products by using bacteria to bind natural materials as an alternative to Portland cement, aimed at concrete producers and the construction industry. Founded in North Carolina with manufacturing and market development in Denmark, the company sells tile products installed in the US and Europe and is developing pavers and walls, with a focus on the European market.

BiotechClimate TechConstruction TechNew Materials

Founders & leadership

Biomason was founded in 2012 by Ginger K. Dosier.

GK
Ginger K. DosierFounder
MF
Michael F. NoelNamed on SEC filing
JM
John M. DosierNamed on SEC filing

Investors · 5

2150✓ verifiedLondon
Novo Holdings✓ verifiedCopenhagen · $1.1M – $54Mvia Anders Bendsen Spohr · board
CarbonAmsterdam · $100K
Celesta CapitalMenlo Park · $5M – $20M
Celesta CapitalSan Francisco

Reported raises · per SEC filings

Form D private placements

$111.6M disclosed across 5 rounds · 2015–2024

▶$36.7MraisedJan 2025 · 6 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Peder Holk-NielsenDirector
  • Michael MarksDirector
  • Niels Christian von Luttichau JolckDirector
  • Michael NoelDirector
  • Anders SpohrDirector
  • Camilo RestrepoExecutive Officer, Director
  • Bradley KnightDirector
  • Lily WachterExecutive Officer
Offering amount
$50.8M
Amount sold
$36.7M
First sale
Dec 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$65MraisedFeb 2022 · 8 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • MICHAEL PETRODirector
  • GINGER K. DOSIERExecutive Officer, Director
  • OLE FALVIG RAMSBYDirector
  • ANDERS BENDSEN SPOHRDirector
  • NIELS CHRISTIAN VON LUTTICHAU JOLCKDirector
  • BRADLEY KNIGHTDirector
  • MICHAEL F. NOELDirector
  • MICHAEL MARKSDirector
Offering amount
$65M
Amount sold
$65M
First sale
Feb 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5MraisedDec 2019 · 1 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Michael F. NoelDirector
  • Ginger M. DosierExecutive Officer, Director
  • Anders M. SpohrDirector
Offering amount
$18M
Amount sold
$5M
First sale
Nov 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3.4MraisedMay 2017 · 4 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Michael F. NoelDirector
  • Ginger K. DosierExecutive Officer, Director
  • John M. DosierExecutive Officer
Offering amount
$7M
Amount sold
$3.4M
First sale
Apr 2017
Incorporated
Corporation, Delaware, 2012
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.5MraisedDec 2015 · 3 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Michael F. NoelDirector
  • John M. DosierExecutive Officer
  • Ginger K. DosierExecutive Officer, Director
Offering amount
$3M
Amount sold
$1.5M
First sale
Dec 2015
Incorporated
Corporation, Delaware, 2012
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Non-dilutive funding · 5 SBIR/STTR awards

Federal grants — no equity taken
AgencyPhaseYearAmount
Defense Advanced Research Projects Agency (DARPA)Defense Advanced Research Projects AgencyPhase II2022$3.8M
ARPA-EPhase II2022$1.5M
ARPA-EPhase I2022$274.4K
National Science FoundationPhase II2015$729K
National Science FoundationPhase I2014$149.9K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

Frequently asked questions

What does Biomason do?
Biomason uses biotechnology to grow biocement, producing concrete and tile products by using bacteria to bind natural materials as an alternative to Portland cement, aimed at concrete producers and the construction industry. Founded in North Carolina with manufacturing and market development in Denmark, the company sells tile products installed in the US and Europe and is developing pavers and walls, with a focus on the European market.
Who founded Biomason?
Biomason was founded by Ginger K. Dosier in 2012.
Who are Biomason's investors?
Biomason's investors include 2150, Novo Holdings, Carbon, Celesta Capital, Celesta Capital.
How much funding has Biomason raised?
Biomason has disclosed $111.6M raised across 5 rounds.
Where is Biomason headquartered?
Biomason is headquartered in Research Triangle Park, US.